phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000017.v3.p1 Whole Genome Association Study of Bipolar Disorder | Versions 1-3: passed embargo
| VDAS | 3261 | Case-Control | Links | AFFY_6.0
|
phs000577.v1.p1 UCDC Longitudinal Study | Version 1: passed embargo
| VDAS | 542 | Longitudinal | Links | |
phs000378.v1.p1 Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia | Version 1: passed embargo
| VDAS | 1251 | Community, Longitudinal, Cross-Sectional | Links | HumanOmni2.5
|
phs001488.v1.p1 Creatine in Huntington's Disease (HD) (CREST-E) | Version 1: passed embargo
| VDAS | 553 | Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial | Links | |
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000125.v1.p1 CIDR: Collaborative Study on the Genetics of Alcoholism (COGA) | Version 1: passed embargo
| VDAS | 1945 | Case-Control | Links | ILLUMINA_Human_1M
|
phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000308.v1.p1 The Glaucoma Genes and Environment (GLAUGEN) Study | Version 1: passed embargo
| VDAS | 2289 | Case-Control | Links | Human660W-Quad_v1_A
|
phs000343.v3.p1 The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial | Versions 1-3: passed embargo
| VDAS | 2164 | Multicenter, Randomized, Clinical Trial, Double-Blind, Controlled Trial | | HumanOmni1-Quad_v1-0_B
|
phs000285.v3.p2 CARDIA Cohort | Versions 1-3: passed embargo
| VDAS | 3622 | Longitudinal | Links | |
phs000576.v1.p1 Angelman Syndrome Natural History Protocol | Version 1: passed embargo
| VDAS | 245 | Case Set | | |
phs000286.v6.p2 The Jackson Heart Study (JHS) | Versions 1-6: passed embargo
| VDAS | 3889 | Cohort | | HiSeq X Ten
|
phs000309.v3.p2 The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs000092.v1.p1 Study of Addiction: Genetics and Environment (SAGE) | Version 1: passed embargo
| VDAS | 4121 | Case-Control | Links | ILMN_Human-1
|
phs000096.v4.p1 HAPO Maternal Glycemia and Birthweight GEI Study | Versions 1-4: passed embargo
| VDAS | 9987 | Prospective, Observational, Cohort | Links | Human1M-Duov3_B Human610_Quadv1_B HumanOmni1-Quad_v1-0_B
|
phs000228.v4.p1 HMP Core Microbiome Sampling Protocol A (HMP-A) | Versions 1-4: passed embargo
| VDAS | 300 | Population-Based Control Set | Links | 454 GS FLX Titanium 454 GS FLX Titanium
|